Global X Genomics & Biotechnology ETF Rating $9.83 -0.21 (-2.09%) Closing price 02/21/2025 03:50 PM EasternExtended Trading$9.83 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.68Holdings in GNOM have an aggregate rating of Moderate Buy based on 497 analyst ratings issued in the past year covering 38 companies (96.6% of the portfolio).GNOM Aggregate Price Target$9.83High Prediction$9.83Average Prediction$9.83Low Prediction$9.83Holdings in GNOM have an aggregate price target of $9.83 and a range of $9.83 to $9.83 covering 38 companies (96.6% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.40%NTRANatera$162.31-3.5%2.574 of 5 stars3.00$170.94 5.3%16Positive News5.42%VCYTVeracyte$39.18-4.6%2.9128 of 5 stars2.67$42.00 7.2%9Analyst DowngradeNews Coverage4.91%BNTXBioNTech$120.01+1.8%2.3788 of 5 stars2.88$142.72 18.9%17Positive NewsGap Down4.56%AAgilent Technologies$135.33-1.1%4.353 of 5 stars2.50$144.38 6.7%14Upcoming EarningsDividend AnnouncementNews CoveragePositive News4.31%BEAMBeam Therapeutics$30.43-8.2%3.1391 of 5 stars3.00$47.67 56.6%12Gap Up4.28%TECHBio-Techne$64.92-0.9%4.9282 of 5 stars2.50$84.29 29.8%8Analyst DowngradeInsider Trade4.26%ARWRArrowhead Pharmaceuticals$19.90-5.1%4.1037 of 5 stars2.60$41.44 108.3%104.20%CRSPCRISPR Therapeutics$47.91-5.0%3.1646 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision4.11%QGENQiagen$39.52+2.5%4.4259 of 5 stars2.30$47.71 20.7%10Analyst Downgrade4.09%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9194 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.99%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.5007 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade3.74%SRPTSarepta Therapeutics$106.28-2.0%4.4948 of 5 stars2.87$176.77 66.3%233.68%LEGNLegend Biotech$39.70+2.0%2.594 of 5 stars3.00$79.50 100.3%12News CoveragePositive News3.53%RAREUltragenyx Pharmaceutical$42.59-4.2%4.6097 of 5 stars2.93$93.50 119.5%14Analyst Forecast3.23%RNAAvidity Biosciences$31.12-4.3%1.613 of 5 stars3.00$65.80 111.4%10Upcoming Earnings3.16%ILMNIllumina$94.20-3.1%4.7685 of 5 stars2.62$159.45 69.3%212.70%GILDGilead Sciences$109.95-0.1%4.7808 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News2.69%MYGNMyriad Genetics$14.19-5.3%3.8474 of 5 stars2.07$22.54 58.8%14Analyst Downgrade2.66%MRNAModerna$35.53+5.3%4.7346 of 5 stars2.04$60.63 70.6%23Analyst DowngradeOptions Volume2.58%CDNACareDx$22.29-4.7%3.7177 of 5 stars2.57$28.33 27.1%7Upcoming EarningsAnalyst DowngradeNews Coverage2.50%TXG10x Genomics$10.90-5.7%4.4013 of 5 stars2.35$20.57 88.7%17Analyst Forecast2.16%VRTXVertex Pharmaceuticals$484.24+0.8%4.1134 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News2.02%NTLAIntellia Therapeutics$12.17-0.7%4.4564 of 5 stars2.72$48.71 300.2%18News CoverageGap Up1.78%VIRVir Biotechnology$9.57-2.3%3.3244 of 5 stars2.83$34.83 264.0%6Insider Trade1.78%RCKTRocket Pharmaceuticals$10.47-3.7%4.521 of 5 stars2.92$47.27 351.5%121.25%QUREuniQure$12.84-0.9%3.3848 of 5 stars3.00$40.00 211.5%10Upcoming Earnings1.02%MRVIMaravai LifeSciences$4.11+4.1%4.0103 of 5 stars2.36$10.28 150.2%11Options VolumeNews CoverageGap UpHigh Trading Volume1.01%VERVVerve Therapeutics$7.28-7.0%2.9224 of 5 stars3.00$25.75 253.7%5Upcoming EarningsAnalyst Forecast0.81%PACBPacific Biosciences of California$1.54-6.1%2.3012 of 5 stars2.54$2.79 81.3%13Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap Up0.70%SANASana Biotechnology$3.01-1.6%3.0556 of 5 stars2.80$14.25 373.4%50.70%FLGTFulgent Genetics$16.46-1.0%3.9372 of 5 stars2.00$22.00 33.7%1Upcoming Earnings0.68%RGNXREGENXBIO$7.27-1.2%3.9077 of 5 stars2.82$33.45 360.2%110.48%SGMOSangamo Therapeutics$1.07-4.5%2.1433 of 5 stars2.67$5.17 382.9%6Positive News0.40%ALLOAllogene Therapeutics$2.17-4.0%2.8233 of 5 stars2.90$9.73 348.5%10Gap Up0.25%TSVT2seventy bio$2.61-2.6%2.0155 of 5 stars2.50$7.20 175.9%6Analyst ForecastNews CoverageGap Up0.22%CRBUCaribou Biosciences$1.31-7.1%3.1282 of 5 stars3.00$10.33 688.8%50.21%EDITEditas Medicine$1.92-7.0%4.6524 of 5 stars2.07$7.00 265.5%14Gap UpHigh Trading Volume0.16%LYELLyell Immunopharma$0.70+6.2%2.1959 of 5 stars1.50$1.00 42.7%2Upcoming EarningsGap Up0.00%SCLXScilex$0.33-1.7%3.3655 of 5 stars3.00$14.00 4,145.0%4 This page (NASDAQ:GNOM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts